Global News

Chiromics, BMS form drug discovery alliance

Tuesday, November 20, 2012 09:39 AM

Chiromics, a drug discovery company based in Princeton, N.J., has formed a strategic research alliance with global biopharmaceutical company Bristol-Myers Squibb.

More... »

CFFT, Pfizer expand collaboration on cystic fibrosis by $58M

Monday, November 19, 2012 02:46 PM

Cystic Fibrosis Foundation Therapeutics (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, has expanded its research collaboration with Pfizer designed to discover new drugs to treat people with the most common mutation of cystic fibrosis (CF), Delta F508.

More... »

Chiromics, GSK enter into collaboration

Monday, November 19, 2012 12:09 PM

Chiromics, a drug discovery company, has formed a collaboration with global healthcare company GlaxoSmithKline to discover novel classes of small molecules against certain biological targets.

More... »

Janssen R&D establishes global cross-pharma clinical trial Investigator Databank

Monday, November 19, 2012 10:18 AM

Janssen Research & Development, based in Raritan, N.J., has established a global cross-pharmaceutical Investigator Databank designed to improve efficiencies of industry-sponsored clinical trials. Merck and Eli Lilly are the first two companies to join Janssen in this effort.

More... »

Aptuit and GSK extend strategic partnership

Monday, November 19, 2012 09:50 AM

Aptuit, a pharmaceutical services company, has reached an agreement on a multi-year extension of its strategic partnership with global healthcare company GlaxoSmithKline (GSK) for dedicated drug development work at The Aptuit Center for Drug Discovery & Development in Verona, Italy. The Verona site—formerly known as GSK’s Medicines Research Centre—was acquired by Aptuit from GSK in 2010.

More... »

Allergan to acquire SkinMedica for $350M

Monday, November 19, 2012 09:22 AM

Allergan, a multi-specialty health care company, has entered into a definitive agreement to acquire SkinMedica, a privately held,  topical aesthetics skin care business.

More... »

Abbott announces phase III Hep C program details

Friday, November 16, 2012 02:25 PM

Abbott Laboratories, a global healthcare company, has released details on its phase III hepatitis C registration program following promising results from its phase IIb clinical trial, known as Aviator.

More... »

Sanofi, T1D Exchange to investigate optimal care for young people with diabetes

Friday, November 16, 2012 02:06 PM

Sanofi, a global healthcare comapny, and T1D Exchange, a non-profit organization focused on type 1 diabetes, will collaborate on the TEENs registry study, which aims to provide the type 1 diabetes community with a better understanding of how children, adolescents and young adults are currently living with type 1 diabetes, and to deliver recommendations for better disease management and patients outcomes.

More... »

ePharmaSolutions launches patient recruitment application for Windows 8

Friday, November 16, 2012 11:43 AM

ePharmaSolutions, a provider of technology-based clinical services based in Conshohocken, Penn., has launched PatientLive, an innovative new patient recruitment application for the new Windows 8 platform.

More... »

Medrio appoints execs from Genentech and NetSuite to board of directors

Thursday, November 15, 2012 08:00 AM

Medrio, a provider of advanced eClinical software as a service (SaaS) for clinical research, has made key appointments to its board of directors: Richard H. Scheller, executive vice president of research at Genentech, and Dave Lipscomb, founder and former executive at NetSuite.

More... »